- World rank, all time
- #34,861 of 42,892
- Rank in Australia
- #592 of 656
- Research works
- 175 ▼ 20% vs 2013–17
- Citations
- 5.3k 30.3 per fractional work
- Top-10% rate
- 9.8% record average 16.5%
- Open access
- 29% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 10.0×. Every wedge is a field page.
- Veterinary 10.0×
- Chemical Engineering 4.9×
- Health Professions 2.8×
- Medicine 2.3×
- Immunology and Microbiology 2.2×
- Psychology 1.7×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Decision Sciences 1.2×
- Agricultural and Biological Sciences 1.0×
- Engineering 0.9×
- Neuroscience 0.9×
- Environmental Science 0.8×
- Energy 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Dentistry 0.3×
- Computer Science 0.3×
- Arts and Humanities 0.2×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Chemistry 0.1×
- Physics and Astronomy 0.1×
Which keywords describe research at Mayne Pharma (Australia)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Global Burden, Risk Factors, Surgical Management, Prognostic Factors, Inflammation, Depression and Quality of Life.
- Disability
- Endoscopic Surgery
- Sentinel Lymph Node Biopsy
- Melanoma
- HPV Vaccination
- Clinical Outcomes
- Mortality Risk
- Chronic Pain
- Human Papillomavirus
- Cancer Incidence
- Patient Satisfaction
- Quality Improvement
- Prevalence
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Depression
- Treatment
- Global Burden
- Inflammation
- Epidemiology
- Risk Factors
- Quality of Life
- Mental Health
- Surgical Management
- Clinical Trials
- Immunotherapy
- Meta-Analysis
- Cardiovascular Risk
- Cervical Cancer
- Radiosurgery
- Chronic Kidney Disease
- Low Back Pain
- Health Outcomes
- Viral Oncoproteins
- Cytology Screening
- Social Determinants of Health
- Reflective Practice
- DNA Methylation
- Degenerative Disc Disease
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology21▲ 3.0×74 topics
- Inflammation6▲ 1.56×38 topics
- Risk Factors6▲ 3.1×20 topics
- Global Burden5▲ 5.5×10 topics
- Quality of Life5▲ 2.0×21 topics
- Treatment4▲ 1.94×27 topics
- Mental Health4▲ 2.1×14 topics
- Depression4▲ 3.0×14 topics
- Surgical Management4▲ 4.9×15 topics
- Prognostic Factors4▲ 4.5×9 topics
- Clinical Trials4▲ 3.2×9 topics
- Chemotherapy3▲ 2.7×13 topics
- Immunotherapy3▲ 2.9×11 topics
- Clinical Practice Guidelines3▲ 2.8×10 topics
- Meta-Analysis3▲ 2.8×12 topics
- Prevalence3▲ 3.9×7 topics
- Cardiovascular Risk3▲ 4.2×8 topics
- Quality Improvement3▲ 7.0×7 topics
- Cervical Cancer2▲ 14×2 topics
- Patient Satisfaction2▲ 5.5×8 topics
- Radiosurgery2▲ 15×4 topics
- Cancer Incidence2▲ 9.0×3 topics
- Chronic Kidney Disease2▲ 5.0×8 topics
- Human Papillomavirus2▲ 10.0×2 topics
- Low Back Pain2▲ 7.1×3 topics
- Chronic Pain2▲ 5.0×5 topics
- Health Outcomes2▲ 4.9×3 topics
- Mortality Risk2▲ 5.7×5 topics
- Viral Oncoproteins2▲ 16×2 topics
- Clinical Outcomes2▲ 5.2×5 topics
- Cytology Screening2▲ 22×1 topic
- HPV Vaccination2▲ 22×1 topic
- Social Determinants of Health2▲ 5.0×2 topics
- Melanoma2▲ 20×2 topics
- Reflective Practice2▲ 5.9×2 topics
- Sentinel Lymph Node Biopsy2▲ 14×2 topics
- DNA Methylation2▲ 8.2×3 topics
- Endoscopic Surgery2▲ 9.0×3 topics
- Degenerative Disc Disease2▲ 10×2 topics
- Disability2▲ 9.8×2 topics
Which research topics does Mayne Pharma (Australia) publish most on?
By volume in 2022–2025: Cutaneous Melanoma Detection and Management, Estrogen and related hormone effects, Carbon Dioxide Capture Technologies and Phase Equilibria and Thermodynamics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cutaneous Melanoma Detection and Management Oncology 1 works
- 2 Estrogen and related hormone effects Genetics 1 works
- 3 Carbon Dioxide Capture Technologies Mechanical Engineering 0 works
- 4 Phase Equilibria and Thermodynamics Biomedical Engineering 0 works
- 5 Nursing Roles and Practices General Health Professions 0 works
- 6 Patient Satisfaction in Healthcare General Health Professions 0 works
- 7 Membrane Separation and Gas Transport Mechanical Engineering 0 works
- 8 Nonmelanoma Skin Cancer Studies Epidemiology 0 works
- 9 Wind and Air Flow Studies Environmental Engineering 0 works
- 10 Primary Care and Health Outcomes General Health Professions 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mayne Pharma (Australia)'s research output changed?
Output in 2018–2022 was 20% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.